About

Company description

Fresenius Kabi Austria is a subsidiary of the global healthcare group Fresenius. The Linz plant is the competence center for manufacturing the APIs Lactulose and Hydroxyethyl starch (HES). With 40 years of expertise in Lactulose production, highest quality standards and a second Lactulose plant in Italy, we rank among the leading global Lactulose producers. We supply liquid and crystalline Lactulose, as bulk or finished product in various containers and sachets, filled and packed on-site. Our plant also houses the world's largest production of HES, which is mainly used in volume therapy. Our plant is cGMP- and ISO-certified.

Quick facts

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America
Affiliated categories: Other APIs |Out-licensing |Sprays More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 60C31 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 3C101 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 836 See our Exhibitor Profile   See full Exhibitor List
24 oct 2017

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany We were at stand 41K02 See our Exhibitor Profile   See full Exhibitor List

Categories affiliated with FRESENIUS KABI AUSTRIA

FRESENIUS KABI AUSTRIA

Contact information

Address

Telephone

Website

View all contact information